Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-cohort, randomized, open, multicenter Phase II study to evaluate the efficacy
and safety of AL2846 capsules in patients with advanced lung cancer and ovarian cancer.
Objective response rate (ORR) and progression-free survival (PFS) are the primary endpoints.